01Jun 2022
Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: a meta‐analysis

Dual‐hormone artificial pancreas for glucose control in type 1 diabetes: a meta‐analysis

This study aims to evaluate the efficacy and safety of DH in type 1 diabetes. 17 randomised crossover trials (438 participants) were included. DH seemed to have a comparable effect on target time compared to SH, but increased time in the target range compared with SAP/CSII and PLGS. DH slightly reduced time in hypoglycemia but could increase the risk of gastrointestinal symptoms compared with SH.

  • #endo-diabetology

Like

Save

Share